Treat the Health Reform Blues with This ETF
Not all areas of the health-care sector would be under the same pressure should sweeping regulation pass. This ETF targets one of them.
The stock market posted another strong month in July, with the Dow and S&P 500 indexes notching gains of 8.6% and 7.4% for the month. After a 46% rally in the S&P since hitting its March 9 lows, the margin of safety offered by Mr. Market has shrunk significantly. Dissecting the market's recent moves reveals that cyclical stocks have led the surge--materials, consumer discretionary, and industrials posted market-beating July gains of 13%, 9.4%, and 9.2%, respectively. Hence we turned our attention to one sector of the market that has lagged: health care.
Certainly, the tremendous amount of uncertainty surrounding the potential effects of the various health-care reform proposals being batted around in Washington is weighing on the sector. However, even in the event that wide-sweeping reform gets signed into law, we don't think that all aspects of the health-care sector will be under the same pressure. Below we highlight one of our favorite health-care plays and explain why we think it is relatively insulated from many of the concerns plaguing the sector.
John Gabriel does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.